Kwon Jin Ah, Rho Hyune Mo
School of Biological Sciences, Seoul National University, Seoul 151-742, Korea.
Biol Chem. 2003 Feb;384(2):203-12. doi: 10.1515/BC.2003.022.
Hepatitis B virus (HBV) is a causative agent of chronic and acute hepatitis, and is associated with the development of hepatocellular carcinoma (HCC). We demonstrate here that the Hepatitis B viral core protein (HBc) functions as a repressor on the promoter activity of the human p53 gene. The functional analyses of the promoter of the p53 gene by serial deletion, site-directed mutagenesis, and the heterologous promoter system revealed that the promoter activity was repressed through the E2F1-binding site (nucleotides -28 to -8) by HBc. An electrophoretic mobility shift assay (EMSA) showed that the HBc reduced the DNA-binding ability of E2F1 to the binding site of the p53 promoter. The interaction of HBc with E2F1 was also observed by glutathione S-transferase (GST) fusion protein binding assay. Furthermore, HBc represses the expression of the p53 gene in the human liver cell line HepG2. Finally, HBc and HBx synergistically repress both the promoter activity and the expression of the p53 gene in HepG2 cells. These results, together with our previous study, strongly suggest that HBc, like HBx, represses the expression of the human p53 tumor suppressor gene.
乙型肝炎病毒(HBV)是慢性和急性肝炎的病原体,与肝细胞癌(HCC)的发生发展相关。我们在此证明,乙型肝炎病毒核心蛋白(HBc)作为人类p53基因启动子活性的抑制因子发挥作用。通过连续缺失、定点诱变和异源启动子系统对p53基因启动子进行功能分析,结果显示HBc通过E2F1结合位点(核苷酸-28至-8)抑制启动子活性。电泳迁移率变动分析(EMSA)表明,HBc降低了E2F1与p53启动子结合位点的DNA结合能力。通过谷胱甘肽S-转移酶(GST)融合蛋白结合试验也观察到了HBc与E2F1的相互作用。此外,HBc抑制人肝癌细胞系HepG2中p53基因的表达。最后,HBc和HBx在HepG2细胞中协同抑制p53基因的启动子活性和表达。这些结果与我们之前的研究一起,有力地表明HBc与HBx一样,抑制人类p53肿瘤抑制基因的表达。